HHS.gov
U.S. Department of Health & Human Services
Home
About HHS
Newsroom
FAQs
Regulations
A-Z Index
Email Updates Font Size Print Download Reader
HHS Home > Blood and Tissue Safety Home > Risk Assessments
Blood and Tissue Safety Home
Biovigilance
Advisory Committee
National Blood Collection & Utilization Survey
Blood and Tissue Preparedness and Response
Risk Assessments
Contact Us
Potential risk of variant Creutzfeld-Jakob Disease (vCJD) in recipients of U.S. licensed plasma-derived products
Status of Immune Globulin Intravenous (IGIV) Products